Shares of Lemonade (NYSE: LMND) soared in after-hours trading last night, goosed by a strong earnings report.
But the gain didn’t last long. Lemonade’s stock took a dive when the market opened on Wednesday. As of 2:20 p.m. ET, I’m looking at a 13% price drop.
Will AI create the world’s first trillionaire? Our team just released a report on the one little-known company, called an “Indispensable Monopoly” providing the critical technology Nvidia and Intel both need. Continue »
Great earnings, so why the sell-off?
The Q1 2026 report was more than solid. Lemonade’s revenue rose 71% year-over-year to $258 million, net losses shrank from $0.86 to $0.47 per share, and both figures beat Wall Street’s consensus targets. The quarterly net loss ratio fell from 82% to 63%, indicating a more efficient insurance business, and Lemonade’s management said that competitors are starting to copy its artificial intelligence (AI) business ideas.
So the initial price jump makes perfect sense. Lemonade enthusiasts embraced the strong numbers and optimistic outlook.
However, Lemonade’s stock carries one of the loftiest price-to-sales multiples in the insurance industry, and the stock has nearly doubled over the last year (after Wednesday’s price drop). That’s enough to inspire some profit-taking, especially among institutional investors and other risk-sensitive groups.
That explains the sharp price drop this morning, as mutual funds, money managers, and other deep-pocketed investors rarely rely on after-hours orders.
Expensive for a reason, or just expensive?
Traditional insurers trade at low price-to-sales multiples because they grow slowly and compete on price in a commoditized market. Lemonade trades at a much higher multiple because it’s growing at 71% and betting that AI can remake the entire insurance value chain.
That’s either visionary or optimistic, depending on your perspective. For now, Lemonade sits in the uncomfortable middle of the growth-stock market; too expensive for value investors, too unprofitable for the cautious, but too fast-growing to ignore.
Personally, I expect big things from Lemonade over time. Its AI systems are still early in their machine learning process, potentially building the foundation of a world-class insurance business for the long haul.
Should you buy stock in Lemonade right now?
Before you buy stock in Lemonade, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Lemonade wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
